Lantheus Holdings Inc., of Billerica, Mass., parent company of Lantheus Medical Imaging Inc. (LMI), reported the sale of its radiopharmacy servicing business in Australia to Global Medical Solutions Ltd. (GMS), of Sherman Oaks, Calif. As part of the transaction, LMI and GMS also entered into a long-term supply and distribution contract under which LMI will continue to supply GMS and its affiliates with LMI's products on commercial terms. The transaction includes Lantheus' radiopharmacy servicing business in greater Melbourne, Victoria and in greater Adelaide, South Australia. These radiopharmacies prepare individual, patient-ready doses of single photon emission computed tomography (SPECT)-based radiopharmaceuticals, which are sold by the radiopharmacies to healthcare providers for administration to patients. The long-term supply and distribution contract provides for Lantheus' products to continue to be available in those markets.
Zimmer Biomet Holdings Inc., of Warsaw, Ind., reported the acquisition of CD Diagnostics Inc., of Claymont, Del. a diagnostics company focused on developing immunoassays and biomarker testing to inform treatment decisions that improve patient outcomes. The financial terms of the transaction were not disclosed. Zimmer Biomet and CD Diagnostics initially partnered in 2012 to co-develop and market diagnostics in the field of musculoskeletal health care. As part of the original agreement, Zimmer Biomet marketed the Synovasure Periprosthetic Joint Infection (PJI) test, the first test specifically designed and validated for the diagnosis of PJI.